Sarcoidosis and tocilizumab: is there a link?

Clin Exp Rheumatol. 2017 Jul-Aug;35(4):716. Epub 2017 May 15.

Authors

Lindsay Bustamente¹, Matthieu Buscot², Charles-Hugo Marquette³, Christian Roux⁴

Affiliations

¹ Rheumatology Department, LAHMESS laboratory, University of Nice Sophia-Antipolis, Hôpital Pasteur 2, Nice, France.
² UMR E-4320 TIRO-MATOs CEA/iBEB, University of Nice Sophia-Antipolis, Faculté de Médecine Nice, France.
³ Pneumology Department, University of Nice Sophia-Antipolis, Hôpital Pasteur 1, Nice, France.
⁴ Rheumatology Department, LAHMESS laboratory, University of Nice Sophia-Antipolis, Hôpital Pasteur 2, Nice, France. roux.c2@chu-nice.fr.

PMID: 28516883

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use*
Antirheumatic Agents / adverse effects*
Arthritis, Rheumatoid / drug therapy*
Dyspnea / etiology
Female
Humans
Lung / diagnostic imaging
Middle Aged
Sarcoidosis / chemically induced
Sarcoidosis, Pulmonary / chemically induced*
Sarcoidosis, Pulmonary / complications
Sarcoidosis, Pulmonary / diagnostic imaging
Tomography, X-Ray Computed
Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

Antibodies, Monoclonal, Humanized
Antirheumatic Agents
Tumor Necrosis Factor-alpha
tocilizumab